ENDOPUMP
The new generation of therapy for Parkinson
Health Tech & Life Sciences
Non Active, May 2022 ceased to operate
Company Overview
Snapshot
Founded in January 2019 by Prof. Moussa Youdim, Tal Youdim, Oded Meiri, and Prof. Eliyahu Heldman, ENDOPUMP operates with 1–10 employees. The company secured its seed funding from Youdim Pharmaceuticals in January 2019.
Business overview
ENDOPUMP is a Health Tech & Life Sciences company focused on developing new generation therapies for Parkinson's disease. Operating within the Pharmaceuticals sector, the company is currently in the R&D product stage, targeting the B2B market with its therapeutic solutions.
Log in to access full profile ›Company Intelligence Q&A
- What is ENDOPUMP's primary focus?
- ENDOPUMP is dedicated to developing new generation therapies for Parkinson's disease, operating within the Health Tech & Life Sciences sector.
- When was ENDOPUMP founded?
- ENDOPUMP was founded in January 2019.
- Who are the founders of ENDOPUMP?
- The company was co-founded by Prof. Moussa Youdim, Tal Youdim, Oded Meiri, and Prof. Eliyahu Heldman.
- What is ENDOPUMP's current operational status?
- ENDOPUMP is currently non-active and ceased to operate in May 2022.